Distribution · Southeast Asia · Announced 23 Oct 2026
Korea United Pharm → Qualimed Pharma
Korea United Pharm signed a US$2.5 million export contract with Qualimed Pharma to supply multiple anticancer products to the Philippines, alongside a separate Vietnam deal, at the GBPP 2026 fair in Korea.
Parties: Korea United Pharm (South Korea) → Qualimed Pharma (Philippines)
- Deal type
- Distribution
- Value
- $2.5m
- Territory
- Philippines
- Therapeutic area
- Oncology
- Asset
- Anticancer portfolio (multiple products, not named)
- Announced
- 23 Oct 2026
Our analysis
Why this matters
Korea United Pharm has signed an export contract worth US$2.5 million with Qualimed Pharma Inc. of the Philippines covering multiple anticancer products. The deal was signed on 21 October 2026 at Global Bio & Pharma Plaza (GBPP) 2026 at KINTEX, an export event hosted by Korea's Ministry of Trade, Industry and Energy and run by KOTRA and the Korea Pharmaceutical Trade Association. It was announced on 23 October together with a US$0.77 million Vietnam contract with Dai Nam Ha Noi JSC, for a combined US$3.27 million.
The individual products and the contract term were not disclosed. The company says the deals show the competitiveness of its anticancer drugs and that it plans to widen its export lines in the Philippines and Vietnam.
The full analysis is free to read with a work email on this page.
Source: Yaksa Gongron (KPA News)